Brielle Benyon

From a 6-year-old cancer survivor visiting all 50 states to give wagons to pediatric patients to Kathy Griffin taking an honest look at cancer and opioid addiction, here’s what’s happening in the cancer space this week.

Social media and the internet as a whole can offer a wealth of information and connections for patients with cancer, especially those with rarer diseases. However, patients should always bring the online advice to their health care team, says Dr. Naveen Pemmaraju.

When both groups had a similar cancer risk, individuals who adopted healthy lifestyles tended to have a lower cancer incidence than those who did not.

Some patients with mantle cell lymphoma can opt for a wait-and-watch approach, while others will need more aggressive treatment.

Patients with a myeloproliferative neoplasm who smoked tended to have worse quality of life than those who did not.

The 60-year-old comedian is optimistic about her prognosis.

Rob Paulsen is the voice behind many beloved cartoon characters, but after receiving a cancer diagnosis, he discovered a whole new way to relate to others.

Bayer, the manufacturer of Roundup, created a five-point plan to decrease the risk of facing future litigation about its product causing cancer.

Patients with myeloma who are receiving Pepaxto should discuss the potential risks and benefits of continued treatment with the drug.

Opdivo was granted an accelerated approval for patients with hepatocellular carcinoma, but the indication was pulled after follow-up data failed to show that the agent improved survival over another drug.

Fewer opioids have been prescribed, but there have been more emergency room visits for pain in patients with cancer who have poor prognoses.

The approval of the immunotherapy agent “has the potential to change the treatment paradigm” in high-risk, early-stage TNBC.

An expert discusses the most common reasons his patients ask him about medical marijuana.

About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.

CURE® offers tips to stay relaxed and healthy during the summer months.

If followed, clinical trial protocols established during the COVID-19 pandemic could allow more patients participate.

More research is needed on how a chronic lymphocytic leukemia diagnosis can affect patients and their caregivers.

The Food and Drug Administration approved Keytruda plus Lenvima for patients with advanced endometrial carcinoma whose disease had progressed after previous systemic therapy and are not candidates for surgery or radiation.

The FDA will expedite the development and review of the drug combination to treat untreated intermediate- high- and very high-risk myelodysplastic syndrome.

After a testicular cancer diagnosis in 2011, CrossFit helped Rory Mckernan get his health back on track. Now, he is helping other cancer survivors do the same.

There is no right decision on if – or how – to reveal a cancer diagnosis in the workplace.

An analysis showed that glycemic index – but not glycemic load or total carbohydrate intake – significantly increased the risk of developing bladder cancer.

When patients with mantle cell lymphoma are discussing the use of a BTK inhibitor, they must consider what their insurance will cover, as well as current health complications and potential side effects.

Most research looked at the broad category of myeloid malignancies, not each individual disease.

Myeloproliferative neoplasms are rare in children. Here are some tips on navigating the uncertainty of a rare cancer diagnosis.

Several sunscreens packaged with aerosol were found to contain benzene, which has been associated with risk of leukemia.

“There’s an infinite amount of information out there, but there’s not an infinite amount of quality information,” said an MPN expert.

Gastrointestinal stromal tumors that are SDH deficient are less likely to respond to TKI treatment. A researcher discusses the exploration of a new drug that can work in this patient population.

Patients with mantle cell lymphoma whose disease relapses within a year and a half of transplant tend to have worse outcomes and may want to consider new treatment regimens.

Patients, clinicians and researchers should work together to find new therapies for rare cancers, one expert says.